Trial Details
COMPLETEDBasic Information
| Clinical ID | c588 |
|---|---|
| Identifier | NCT05452187 |
| Trial Title | Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Hepatitis C Virus Infection |
| Interventions | DRUG: Assess the effectiveness and safety of DAAs in patients with IBD.|DRUG: Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics.|OTHER: Assessment of the impact of DAAs on the course of IBD. |
Participant Information
| Sponsor | Hospital Mutua de Terrassa |
|---|---|
| City | Terrassa |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2021-03-12 |
|---|---|
| Primary Completion Date | 2021-07-30 |
| Completion Date | 2021-12-20 |